{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T22:06:40Z","timestamp":1776722800000,"version":"3.51.2"},"reference-count":15,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reports"],"abstract":"<jats:p>Background and Clinical Significance: Non-bacterial thrombotic endocarditis (NBTE), historically termed marantic endocarditis, is a severe manifestation of cancer-associated hypercoagulability characterized by sterile valvular vegetations and a high risk of systemic embolization. While direct oral anticoagulants (DOACs) have become the standard of care for cancer-associated venous thromboembolism (CAT), their efficacy in preventing high-shear arterial thrombosis in NBTE has been contested. Emerging data suggest that DOACs may fail to halt vegetation growth in active malignancy, necessitating a reversion to heparin-based therapies. Case Presentation: A 47-year-old female with metastatic RET fusion-positive non-small cell lung cancer (NSCLC) presented with progressive dyspnea and digital ischemia despite strict adherence to therapeutic anticoagulation with rivaroxaban for a prior pulmonary embolism. Echocardiography showed large vegetations on all three cusps of the aortic valve, confirming NBTE. Computed tomography revealed extensive tumor progression. The therapeutic strategy involved an immediate switch from rivaroxaban to therapeutic low-molecular-weight heparin (LMWH) and the initiation of dual targeted therapy with selpercatinib and tepotinib. Serial transesophageal echocardiography documented regression within two weeks and eventual complete resolution of the valvular vegetations after eight weeks, occurring in tandem with a rapid radiological response of the tumor. Conclusions: Upon diagnosis of NBTE, a rapid oncologic work-up is warranted, as ongoing tumor progression is highly likely. This case questions the appropriateness of direct oral anticoagulants in patients with NBTE and active, progressive malignancy.<\/jats:p>","DOI":"10.3390\/reports9010074","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T15:22:21Z","timestamp":1772551341000},"page":"74","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Reversal of Paraneoplastic Non-Bacterial Thrombotic Endocarditis with Heparin and Targeted Cancer Therapy: A Case Report"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-1333-5558","authenticated-orcid":false,"given":"Collin","family":"Goetze","sequence":"first","affiliation":[{"name":"Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charit\u00e9 (DHZC), Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, 13353 Berlin, Germany"},{"name":"DZHK (German Center for Cardiovascular Research), 10785 Berlin, Germany"},{"name":"Faculty of Medicine, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7452-7129","authenticated-orcid":false,"given":"Nikolaj","family":"Frost","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany"},{"name":"Department of Infectious Diseases and Pulmonary Medicine, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, 13353 Berlin, Germany"},{"name":"National Center for Tumor Diseases (NCT), 13353 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingo","family":"Hilgendorf","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charit\u00e9 (DHZC), Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, 13353 Berlin, Germany"},{"name":"DZHK (German Center for Cardiovascular Research), 10785 Berlin, Germany"},{"name":"Faculty of Medicine, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8655-7691","authenticated-orcid":false,"given":"Daniel Armando","family":"Morris","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charit\u00e9 (DHZC), Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, 13353 Berlin, Germany"},{"name":"DZHK (German Center for Cardiovascular Research), 10785 Berlin, Germany"},{"name":"Faculty of Medicine, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6320-3708","authenticated-orcid":false,"given":"Matthias","family":"Schneider-Reigbert","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charit\u00e9 (DHZC), Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, 13353 Berlin, Germany"},{"name":"DZHK (German Center for Cardiovascular Research), 10785 Berlin, Germany"},{"name":"Faculty of Medicine, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.ejcts.2007.07.029","article-title":"Non-bacterial thrombotic endocarditis","volume":"32","author":"Asopa","year":"2007","journal-title":"Eur. J. Cardio-Thorac. Surgery"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.thromres.2011.01.002","article-title":"Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism","volume":"127","author":"Campello","year":"2011","journal-title":"Thromb. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.amjmed.2020.06.047","article-title":"A Contemporary 20-Year Cleveland Clinic Experience of Nonbacterial Thrombotic Endocarditis: Etiology, Echocardiographic Imaging, Management, and Outcomes","volume":"134","author":"Zmaili","year":"2021","journal-title":"Am. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/jth.12070","article-title":"International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer","volume":"11","author":"Farge","year":"2013","journal-title":"J. Thromb. Haemost."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s11239-019-01871-4","article-title":"Efficacy and safety of direct oral anticoagulants versus low-molecular-weight heparin in patients with cancer: A systematic review and meta-analysis","volume":"48","author":"Dong","year":"2019","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13045-022-01289-1","article-title":"Direct oral anticoagulant versus low molecular weight heparin for the treatment of cancer-associated venous thromboembolism: 2022 updated systematic review and meta-analysis of randomized controlled trials","volume":"15","author":"Frere","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"ytaf463","DOI":"10.1093\/ehjcr\/ytaf463","article-title":"Failure of oral anti-Xa to prevent non-bacterial thrombotic endocarditis in cancer: Case report and literature review","volume":"9","author":"Benjelloun","year":"2025","journal-title":"Eur. Heart J. Case Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.thromres.2006.10.026","article-title":"The anti-inflammatory effects of heparin and related compounds","volume":"122","author":"Young","year":"2008","journal-title":"Thromb. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1634\/theoncologist.12-5-518","article-title":"Nonbacterial thrombotic endocarditis in cancer patients: Pathogenesis, diagnosis, and treatment","volume":"12","author":"Griffiths","year":"2007","journal-title":"Oncologist"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1093\/ehjci\/jeac252","article-title":"Non-bacterial thrombotic endocarditis: A highly dynamic entity with rapid response to initiation and discontinuation of heparin","volume":"24","author":"Zach","year":"2023","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.21037\/apm-21-251","article-title":"Management of nonbacterial thrombotic endocarditis (NBTE) in advanced non-small cell lung cancer (NSCLC) patients with driver mutation: Two case reports","volume":"10","author":"Xie","year":"2021","journal-title":"Ann. Palliat. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1093\/ehjci\/jeac196","article-title":"The marantic kiss: Potential novel pathognomonic echocardiographic sign of non-bacterial thrombotic endocarditis","volume":"24","author":"Schneider","year":"2022","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-197756010-00001","article-title":"Trousseau\u2019s syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: Clinical, pathophysiologic, and therapeutic features","volume":"56","author":"Sack","year":"1977","journal-title":"Medicine"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/0002-9343(87)90908-9","article-title":"Cerebral infarction from non-bacterial thrombotic endocarditis. Clinical and pathological study including the effects of anticoagulation","volume":"83","author":"Rogers","year":"1987","journal-title":"Am. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-1-60761-803-4_3","article-title":"Heparin and low-molecular weight heparins in thrombosis and beyond","volume":"663","author":"Mousa","year":"2010","journal-title":"Methods Mol. Biol."}],"container-title":["Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2571-841X\/9\/1\/74\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T16:29:10Z","timestamp":1772555350000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2571-841X\/9\/1\/74"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,28]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["reports9010074"],"URL":"https:\/\/doi.org\/10.3390\/reports9010074","relation":{},"ISSN":["2571-841X"],"issn-type":[{"value":"2571-841X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,28]]}}}